Gilead Sciences: Stop Worrying About Hepatitis C. This is What You Should Be Paying Attention To
October 25, 2016 at 12:36 PM EDT
Jefferies analyst Brian Abrahams and team contend that the Street missed the importance of last week's NASH data from Gilead Sciences ( GILD ). They explain why:
